{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:10:52Z","timestamp":1783210252464,"version":"3.54.6"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control","doi-asserted-by":"publisher","award":["5U51PS004607\u201302"],"award-info":[{"award-number":["5U51PS004607\u201302"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hepatitis C infection could be eliminated. Underdiagnosis and lack of treatment are the barriers to cure, especially for vulnerable populations (i.e. unable to pay for health care).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A multilevel intervention from September 2014 to September 2019 focused on the providers and organizations in \u2018the safety net\u2019 (providing health care to populations unable to pay), including: (i) public education, (ii) training for primary care providers (PCPs) and case managers, (iii) case management for high-risk populations, (iv) policy advice and (v) a registry (Registry) for 13 health centers contributing data. The project tracked the number of PCPs trained and, among Registry sites, the number of people screened, engaged in care (i.e. clinical follow-up after diagnosis), treated and\/or cured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In Chicago, 215 prescribing PCPs and 56 other health professionals, 86% of whom work in the safety net, were trained to manage hepatitis C. Among Registry sites, there was a 137% increase in antibody screening and a 32% increase in current hepatitis C diagnoses. Engagement in care rose by 18%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Hepatitis C Community Alliance to Test and Treat (HepCCATT) successfully targeted safety net providers and organizations with a comprehensive care approach. While there were challenges, HepCCATT observed increased hepatitis C screening, diagnosis and engagement in care in the Chicago community.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pubmed\/fdab190","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T19:48:53Z","timestamp":1622231333000},"page":"891-899","source":"Crossref","is-referenced-by-count":2,"title":["HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago"],"prefix":"10.1093","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1990-1197","authenticated-orcid":false,"given":"Sandra","family":"Tilmon","sequence":"first","affiliation":[{"name":"Academic Pediatrics , University of Chicago Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Aronsohn","sequence":"additional","affiliation":[{"name":"Gastroenterology , University of Chicago Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Boodram","sequence":"additional","affiliation":[{"name":"Department of Public Health , University of Illinois at Chicago, Chicago, IL 60607, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Canary","sequence":"additional","affiliation":[{"name":"CDC: Division of Viral Hepatitis , National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Goel","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Geriatrics , Northwestern University (Medicine), Chicago, IL 60611 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hamlish","sequence":"additional","affiliation":[{"name":"Cancer Center , University of Illinois at Chicago, Chicago, IL 60612 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kemble","sequence":"additional","affiliation":[{"name":"Hawaii Department of Health , Honolulu, HI 96813, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D S","family":"Lauderdale","sequence":"additional","affiliation":[{"name":"Public Health Sciences , University of Chicago Medicine, Chicago, IL 60637"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Layden","sequence":"additional","affiliation":[{"name":"Illinois Department of Public Health , West Chicago, IL 60185, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Lee","sequence":"additional","affiliation":[{"name":"Academic Pediatrics , University of Chicago Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Millman","sequence":"additional","affiliation":[{"name":"CDC: Division of Viral Hepatitis , National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Nelson","sequence":"additional","affiliation":[{"name":"CDC: Division of Viral Hepatitis , National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA 30329, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ritger","sequence":"additional","affiliation":[{"name":"Chicago Department of Public Health , Chicago, IL 60604, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"Academic Pediatrics , University of Chicago Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Shurupova","sequence":"additional","affiliation":[{"name":"Medical Research Analytics and Informatics Alliance (MRAIA) , Chicago, IL 60606, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wolf","sequence":"additional","affiliation":[{"name":"Caring Ambassadors Program , Oregon City, OR 97045, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Johnson","sequence":"additional","affiliation":[{"name":"Academic Pediatrics , University of Chicago Medicine, Chicago, IL 60637, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"5 Suppl 1","key":"2023080905263262700_ref1","first-page":"S21","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"issue":"7","key":"2023080905263262700_ref2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00535-007-2064-6","article-title":"The epidemiology of hepatitis C infection in the United States","volume":"42","author":"Rustgi","year":"2007","journal-title":"J Gastroenterol"},{"issue":"4","key":"2023080905263262700_ref3","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3748\/wjg.v22.i4.1357","article-title":"Liver pathology of hepatitis C, beyond grading and staging of the disease","volume":"22","author":"Dhingra","year":"2016  28","journal-title":"World J Gastroenterol"},{"issue":"3","key":"2023080905263262700_ref4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister","year":"2019","journal-title":"Hepatology"},{"issue":"RR-19","key":"2023080905263262700_ref5","first-page":"1","article-title":"Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention","volume":"47","year":"1998  16","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"2023080905263262700_ref6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/infdis\/145.6.886","article-title":"Sporadic non-A, non-B hepatitis: frequency and epidemiology in an urban U.S. population","volume":"145","author":"Alter","year":"1982","journal-title":"J Infect Dis"},{"issue":"2","key":"2023080905263262700_ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014","volume":"108","author":"Zibbell","year":"2017  21","journal-title":"Am J Public Health"},{"issue":"13","key":"2023080905263262700_ref8","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa1009482","article-title":"Boceprevir for previously treated chronic HCV genotype 1 infection","volume":"364","author":"Bacon","year":"2011  31","journal-title":"N Engl J Med"},{"key":"2023080905263262700_ref9","volume-title":"Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report [Internet]","author":"Committee on a National Strategy for the Elimination of Hepatitis B and C, Board on Population Health and Public Health Practice, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine","year":"2016"},{"issue":"9","key":"2023080905263262700_ref10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41395-018-0033-8","article-title":"Race\/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment","volume":"113","author":"Wong","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"2023080905263262700_ref11","volume-title":"Americas\u2019s Health Care Safety Net: Intact but Endangered [Internet]","author":"Institute of Medicine (US) Committee on the Changing Market, Managed Care, and the Future Viability of Safety Net Providers","year":"2000"},{"key":"2023080905263262700_ref12","volume-title":"QuickFacts: Chicago City, Illinois [Internet]","author":"United States Census Bureau"},{"key":"2023080905263262700_ref13","volume-title":"Hepatitis C Surveillance Report\u2013 Chicago, 2016 [Internet]","author":"Chicago Department of Public Health","year":"2018"},{"key":"2023080905263262700_ref14","volume-title":"Hepatitis C Surveillance Report - Chicago","author":"Chicago Department of Public Health","year":"2019"},{"key":"2023080905263262700_ref15","volume-title":"2016ChicagoOpioidReport.pdf [Internet]"},{"key":"2023080905263262700_ref16","first-page":"12","volume-title":"Annual Opioid Surveillance Report \u2013 Chicago 2017","author":"Rushovich","year":"2018"},{"issue":"9615","key":"2023080905263262700_ref17","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","article-title":"Liver cirrhosis","volume":"371","author":"Schuppan","year":"2008  8","journal-title":"Lancet"},{"key":"2023080905263262700_ref18","volume-title":"Prior Authorization of Sovaldi and Other Medications for the Treatment of Chronic Hepatitis C [Internet]","author":"Illinois Department of Healthcare and Family Services"},{"key":"2023080905263262700_ref19","volume-title":"Provider Notice issued 09\/30\/16 Hepatitis C Treatment [Internet]","author":"Illinois Department of Healthcare and Family Services","year":"2016"},{"key":"2023080905263262700_ref20","volume-title":"Criteria for Prior Approval of Direct-Acting Antivirals (DAAs) for Hepatitis C [Internet]","author":"Illinois Department of Healthcare and Family Services","year":"2018"},{"issue":"10178","key":"2023080905263262700_ref21","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(18)32750-8","article-title":"How feasible is the global elimination of HCV infection?","volume":"393","author":"Wiktor","year":"2019  30","journal-title":"Lancet"},{"issue":"10178","key":"2023080905263262700_ref22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/S0140-6736(18)32277-3","article-title":"Scaling up prevention and treatment towards the elimination of hepatitis C: a global mathematical model","volume":"393","author":"Heffernan","year":"2019  30","journal-title":"Lancet"},{"key":"2023080905263262700_ref23","volume-title":"Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C. [Internet]","author":"Institute of Medicine","year":"2010"},{"key":"2023080905263262700_ref24","volume-title":"A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report [Internet]","author":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on a National Strategy for the Elimination of Hepatitis B and C","year":"2017"},{"key":"2023080905263262700_ref25","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.15892.1","article-title":"Hepatitis C elimination: challenges with under-diagnosis and under-treatment","volume":"8","author":"Terrault","year":"2019","journal-title":"F1000Res"},{"issue":"2","key":"2023080905263262700_ref26","article-title":"Academic health center management of chronic diseases through knowledge networks: Project ECHO","volume":"82","author":"Arora","year":"2007","journal-title":"Acad Med [Internet]"},{"key":"2023080905263262700_ref27","volume-title":"Know More Hepatitis | CDC [Internet]","year":"2019"},{"issue":"4","key":"2023080905263262700_ref28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1353\/cpr.2013.0043","article-title":"Evaluating the role of key learning theories in ECHO: a telehealth educational program for primary care providers","volume":"7","author":"Socolovsky","year":"2013","journal-title":"Prog Community Health Partnersh"},{"issue":"2","key":"2023080905263262700_ref29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/FCH.0000000000000253","article-title":"Case management and capacity building to enhance hepatitis C treatment uptake at community health centers in a large urban setting","volume":"43","author":"Boodram","year":"2020","journal-title":"Fam Community Health."},{"key":"2023080905263262700_ref30","volume-title":"Code of Civil Procedure, Part 21. Medical Studies, Article VIII Jun 6","author":"Illinois Medical Studies Act","year":"2016"},{"issue":"3","key":"2023080905263262700_ref31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"2023080905263262700_ref32","volume-title":"Data Classification Methods\u2014ArcGIS Pro | ArcGIS Desktop [Internet]"},{"key":"2023080905263262700_ref33","volume-title":"Illinois Safety Net Hospitals [Internet]. Illinois Health and Hospital Association: Illinois Safety Net Hospitals","author":"Illinois Health and Hospital Association"},{"issue":"8","key":"2023080905263262700_ref34","doi-asserted-by":"crossref","first-page":"e198577","DOI":"10.1001\/jamanetworkopen.2019.8577","article-title":"Comparison of 3 Safety-Net Hospital Definitions and Association With Hospital Characteristics","volume":"2","author":"Popescu","year":"2019  2","journal-title":"JAMA Netw Open"},{"key":"2023080905263262700_ref35","first-page":"38","volume-title":"Hepatitis C Annual Surveillance Report (Appendix C - Supplemental Data Tables, Table 2. Number of Cases and Rates of Chronic Hepatitis C Saint Louis County, MO, 2013 to 2017) [Internet]","author":"Saint Louis County Department of Public Health","year":"2018"},{"key":"2023080905263262700_ref36","volume-title":"Division of Public Health. Wisconsin Hepatitis C Virus Surveillance Annual Review, 2017. Newly Reported Cases, Prevalent Cases, and Trends (Table 3. newly reported HCV by county of residence) [Internet]","author":"Wisconsin Department of Health Services","year":"2018"}],"container-title":["Journal of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpubhealth\/article-pdf\/44\/4\/891\/51065921\/fdab190.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpubhealth\/article-pdf\/44\/4\/891\/51065921\/fdab190.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T05:27:10Z","timestamp":1691558830000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpubhealth\/article\/44\/4\/891\/6307492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,6,22]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/pubmed\/fdab190","relation":{},"ISSN":["1741-3842","1741-3850"],"issn-type":[{"value":"1741-3842","type":"print"},{"value":"1741-3850","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2021,6,22]]}}}